GlassScriptPhysician profile
Wesley Anderson
NPI 1851811053
$2,691.39
in general payments reported to CMS, 2019-2025
22 companies · $685 in 2025
The $685 reported for 2025 was more than what 83% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.65 · 2022: $180 · 2023: $1,130 · 2024: $644 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,459.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $622.17 | 2021-2025 | Avvigo Guidance System, Rotapro, Watchman Flx |
| Abbott Laboratories | $483.37 | 2022-2025 | Diamondback Coronary, Thoratec Heartmate 3 Lvas Implant Kit, Perclose Prostyle |
| Abiomed | $446.17 | 2023-2025 | Impella |
| Stryker Corporation | $169.83 | 2025 | Flowtriever |
| E.R. Squibb & Sons, L.L.C. | $164.81 | 2022-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $146.97 | 2022-2024 | Brilinta |
| Amgen INC. | $97.23 | 2023-2024 | Repatha |
| Chiesi USA, INC. | $85.91 | 2023-2024 | Kengreal, Cleviprex |
| Pfizer INC. | $80.31 | 2021-2024 | |
| Novo Nordisk INC | $69.74 | 2023-2024 | Ozempic |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Novartis Pharmaceuticals Corporation | $46.05 | 2024-2025 | |
| Atricure, INC. | $41.70 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Janssen Pharmaceuticals, INC | $35.02 | 2024 | Xarelto |
| Edwards Lifesciences Corporation | $28.14 | 2025 | Sapien 3 Ultra Resilia |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $19.79 | 2025 | Alphavac |
| Medtronic, INC. | $18.94 | 2023 | Onyx Frontier |
| Lantheus Medical Imaging, INC. | $18.57 | 2021 | |
| Inari Medical, INC. | $17.80 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Terumo Medical Corporation | $17.59 | 2022 | |
| Merck Sharp & Dohme LLC | $16.69 | 2023 | Verquvo |
| Philips North America LLC | $16.59 | 2025 | Elca |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.